Publicaciones en las que colabora con Francisco Jorquera Plaza (7)

2024

  1. Idiosyncratic Drug-Induced Liver Injury and Amoxicillin–Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

2019

  1. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 275-282

  2. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

    Molecular Nutrition and Food Research, Vol. 63, Núm. 8

2014

  1. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin

    Laboratory Investigation, Vol. 94, Núm. 3, pp. 262-274

2012

  1. Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication

    Laboratory Investigation, Vol. 92, Núm. 8, pp. 1191-1202

2005

  1. Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C

    Journal of Gastroenterology and Hepatology (Australia), Vol. 20, Núm. 4, pp. 547-554

2003

  1. Rabbit hemorrhagic viral disease: Characterization of a new animal model of fulminant liver failure

    Journal of Laboratory and Clinical Medicine, Vol. 141, Núm. 4, pp. 272-278